Back to Products
Lead Product

Microbiome-Based Diagnostics for Diabetic Foot Ulcer Risk

AI-powered point-of-care diagnostics for rapid risk stratification in diabetic foot ulcers — results in 10-15 minutes.

77M+
Diabetics in India
10-15M
High-Risk for DFU
1,000+
Clinical Cases Analyzed

The Problem

48-72h

Culture-based testing is slow and lab-dependent

Expensive

Advanced testing is costly and limited in low-resource settings

No Prediction

No existing solution predicts risk before infection escalates

Our Solution

Multi-Target Detection

Combinatorial approach captures diverse pathogen profiles specific to diabetic foot infections.

Multiplex LFA Technology

Simultaneous detection of multiple markers in a single, easy-to-use test strip — results in 10-15 minutes.

ML-Driven Risk Index

Machine learning algorithms analyze marker patterns to generate clinically actionable risk scores.

Smartphone Integration

Mobile app provides instant results interpretation, data capture, and clinical decision support.

DFU Multiplex Assay
Control
Target A
Target B
Target C
Risk Assessment
Moderate Risk
Smartphone Interpreted

Three-Zone Risk Stratification

Clear classification guides treatment decisions and enables early intervention

Low Risk

Routine monitoring, standard care protocols

Moderate Risk

Enhanced surveillance, preventive intervention

High Risk

Immediate clinical action, specialist referral

Interested in Our DFU Diagnostics?

We're seeking clinical partnerships, investment, and collaboration.

Contact Us